US2008319173A1PendingUtilityA1

Blood group antigen fusion polypeptides and methods of use thereof

Assignee: LOFLING JONASPriority: Jul 20, 2001Filed: Jan 30, 2008Published: Dec 25, 2008
Est. expiryJul 20, 2021(expired)· nominal 20-yr term from priority
A61P 39/00A61P 37/06C07K 2319/00Y10S530/866C07K 2319/30A61K 38/1709C07K 14/4727
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides compositions and methods for treating or preventing antibody mediated graft rejection.

Claims

exact text as granted — not AI-modified
1 . An absorber comprising a fusion polypeptide, wherein the fusion polypeptide comprises a first polypeptide operably linked to a second polypeptide, wherein the first polypeptide:
 (a) is a mucin polypeptide and   (b) is glycosylated by an α1,2 fucosyltransferase and   the second polypeptide comprises at least a region of an immunoglobulin polypeptide.   
     
     
         2 . A method removing an antibody from a biological sample, the method comprising
 (a) contacting a biological sample with the absorber of  claim 1  to form an absorber-antibody complex; and   (b) removing the complex from the biological sample thereby removing the antibody from the biological sample.

Join the waitlist — get patent alerts

Track US2008319173A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.